tiprankstipranks
Advertisement
Advertisement

OCGN Stock Latest News

Ocugen inks OCU400 licensing deal for MENA
Company AnnouncementsOcugen inks OCU400 licensing deal for MENA
13s ago
8K
OCGN
Ocugen announces $4M OCU400 license agreement with Roots Pharmaceutical
PremiumThe Fly
Ocugen announces $4M OCU400 license agreement with Roots Pharmaceutical
6h ago
OCGN
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
11d ago
CGC
CPB
Nasdaq, Take-Two, Fastly, Ocugen, Sony Insider Shock
PremiumWeekend Updates
Nasdaq, Take-Two, Fastly, Ocugen, Sony Insider Shock
23d ago
FSLY
NDAQ
Ocugen Stockholders Approve Proposals and Confirm Leadership
PremiumCompany Announcements
Ocugen Stockholders Approve Proposals and Confirm Leadership
1M ago
8K
OCGN
Ocugen Consolidates Financial Leadership Under New Accounting Officer
PremiumCompany AnnouncementsOcugen Consolidates Financial Leadership Under New Accounting Officer
1M ago
8K
OCGN
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
NFE
YSS
Ocugen price target lowered to $11 from $12 at Canaccord
Premium
The Fly
Ocugen price target lowered to $11 from $12 at Canaccord
2M ago
OCGN
5 Healthcare Stocks Set to Join the Russell 3000
PremiumMarket News
5 Healthcare Stocks Set to Join the Russell 3000
2M ago
QSI
AGEN
Ocugen Raises $130 Million Through Convertible Notes Offering
PremiumCompany Announcements
Ocugen Raises $130 Million Through Convertible Notes Offering
2M ago
8K
OCGN
Ocugen Announces Interim Chief Medical Officer Appointment Transition
PremiumCompany Announcements
Ocugen Announces Interim Chief Medical Officer Appointment Transition
2M ago
8K
OCGN
Ocugen Maintained at Buy as Analyst Cites Compelling Gene Therapy Data and Keeps $12 Price Target Unchanged
PremiumRatings
Ocugen Maintained at Buy as Analyst Cites Compelling Gene Therapy Data and Keeps $12 Price Target Unchanged
2M ago
OCGN
Ocugen Raises Capital Through Convertible Senior Notes Offering
PremiumCompany AnnouncementsOcugen Raises Capital Through Convertible Senior Notes Offering
2M ago
8K
OCGN
Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
Premium
Company Announcements
Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
2M ago
8K
OCGN
Ocugen reports Q1 EPS (6c), consensus (5c)
Premium
The Fly
Ocugen reports Q1 EPS (6c), consensus (5c)
2M ago
OCGN
Ocugen Announces Private Convertible Notes Offering to Deleverage
PremiumCompany Announcements
Ocugen Announces Private Convertible Notes Offering to Deleverage
2M ago
8K
OCGN
Ocugen announces private offering of $115M of convertible senior notes
PremiumThe Fly
Ocugen announces private offering of $115M of convertible senior notes
2M ago
OCGN
Ocugen: Buy Rating Reiterated as Analyst Highlights Retinal Pipeline Upside and Maintains $12 Price Target
PremiumRatings
Ocugen: Buy Rating Reiterated as Analyst Highlights Retinal Pipeline Upside and Maintains $12 Price Target
2M ago
OCGN
OCGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OCGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
OCGN
Ocugen completes dosing in GARDian3 trial
PremiumThe FlyOcugen completes dosing in GARDian3 trial
3M ago
OCGN
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
Premium
The Fly
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
3M ago
ANNX
APLS
Ocugen Updates Roadmap for Gene-Agnostic Retinal Therapies
Premium
Company Announcements
Ocugen Updates Roadmap for Gene-Agnostic Retinal Therapies
4M ago
8K
OCGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >